mRNA |
AC55649 |
CTRPv2 |
pan-cancer |
AAC |
0.067 |
0.08 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.11 |
0.08 |
mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.09 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.09 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.09 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.09 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |